Revolution Medicines Warrant Stock Alpha and Beta Analysis
| RVMDW Stock | 1.85 0.17 10.12% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Revolution Medicines Warrant. It also helps investors analyze the systematic and unsystematic risks associated with investing in Revolution Medicines over a specified time horizon. Remember, high Revolution Medicines' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Revolution Medicines' market risk premium analysis include:
Beta 3.18 | Alpha 3.24 | Risk 18.59 | Sharpe Ratio 0.17 | Expected Return 3.14 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Revolution | Build AI portfolio with Revolution Stock |
Revolution Medicines Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Revolution Medicines market risk premium is the additional return an investor will receive from holding Revolution Medicines long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Revolution Medicines. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Revolution Medicines' performance over market.| α | 3.24 | β | 3.18 |
Revolution Medicines expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Revolution Medicines' Buy-and-hold return. Our buy-and-hold chart shows how Revolution Medicines performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Revolution Medicines Market Price Analysis
Market price analysis indicators help investors to evaluate how Revolution Medicines stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Revolution Medicines shares will generate the highest return on investment. By understating and applying Revolution Medicines stock market price indicators, traders can identify Revolution Medicines position entry and exit signals to maximize returns.
Revolution Medicines Return and Market Media
The median price of Revolution Medicines for the period between Sat, Nov 22, 2025 and Fri, Feb 20, 2026 is 0.94 with a coefficient of variation of 63.45. The daily time series for the period is distributed with a sample standard deviation of 0.87, arithmetic mean of 1.37, and mean deviation of 0.69. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Disposition of 3000 shares by Mark Goldsmith of Revolution Medicines, at 75.0 subject to Rule 16b-3 | 11/25/2025 |
2 | Disposition of 3104 shares by Jack Anders of Revolution Medicines at 77.0904 subject to Rule 16b-3 | 12/16/2025 |
3 | Why Revolution Medicines Inc. Equity Warrant stock could outperform in 2025 - Quarterly Performance Summary Weekly Momentum Stock Picks - | 12/19/2025 |
4 | BofA Securities Maintains Revolution Medicines With Buy Rating, Raises Target Price to 98 - | 01/06/2026 |
5 | Why Revolution Medicines Stock Surged by 11 percent Today - Nasdaq | 01/09/2026 |
6 | Technical Analysis How much upside does Revolution Medicines Inc Equity Warrant have - 2025 Support Resistance Consistent Profit Trading Strategies - baoquankhu... | 01/13/2026 |
7 | Disposition of 908 shares by Cislini Jeff of Revolution Medicines at 115.6 subject to Rule 16b-3 | 01/21/2026 |
8 | Macro Review Is TRUE showing insider buying - July 2025 Reactions Consistent Growth Equity Picks - baoquankhu1.vn | 01/23/2026 |
9 | 48,000 RAS G12V cancer cases a year as Revolution Medicines trials new drug - Stock Titan | 01/29/2026 |
10 | Short Interest in Revolution Medicines, Inc. Drops By 91.3 | 02/11/2026 |
11 | Acquisition by Mark Goldsmith of 20000 shares of Revolution Medicines at 4.09 subject to Rule 16b-3 | 02/17/2026 |
About Revolution Medicines Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Revolution or other stocks. Alpha measures the amount that position in Revolution Medicines has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2023 | 2025 | 2026 (projected) | Days Sales Outstanding | 39.53 | 45.45 | 75.46 | PTB Ratio | 1.78 | 3.72 | 3.54 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Revolution Medicines in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Revolution Medicines' short interest history, or implied volatility extrapolated from Revolution Medicines options trading.
Build Portfolio with Revolution Medicines
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Revolution Stock Analysis
When running Revolution Medicines' price analysis, check to measure Revolution Medicines' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revolution Medicines is operating at the current time. Most of Revolution Medicines' value examination focuses on studying past and present price action to predict the probability of Revolution Medicines' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revolution Medicines' price. Additionally, you may evaluate how the addition of Revolution Medicines to your portfolios can decrease your overall portfolio volatility.